Expert panel recommends Bharat Biotech s Covaxin for emergency use mid-day.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from mid-day.com Daily Mail and Mail on Sunday newspapers.
India clears Covaxin, ‘certain conditions’ follow Bharat Biotech vaccine gets emergency use authorisation from CDSCO
Covaxin, the anti-coronavirus vaccine developed indigenously by India’s Hyderabad-based Bharat Biotech, has received restricted emergency use permission, with certain conditions, from an expert panel of India s central drug authority on Saturday, sources said.
Covaxin has been developed by the Hyderabad-based company in collaboration with the Indian Council of Medical Research (ICMR).
The Union Health Ministry on Saturday also confirmed that the Subject Expert Committee (SEC) of the Central Drugs Standard Control Organisation (CDSCO) has recommended granting permission to the Serum Institute of Institute (SII) for restricted emergency use of Covishield in India, subject to multiple regulatory conditionalities.
Covid vaccine dry run held in all states across India: 10 points
A health worker conducts the vaccination mock drill and dry run in Bhubaneswar on Saturday.
(PTI)
Share Via
Read Full Story
The dry run drill for administering coronavirus vaccines and plug loopholes in logistics and training has started in all the states and Union Territories across the country.
Union Health Minister Dr Harsh Vardhan on Saturday visited two mock vaccination sites in the national capital to review the Covid-19 vaccination drive.
TRENDING STORIESSee All
2 min read
India s second covid wave may last up to 100 days: SBI report
3 min read
Meeting On Covid-19 Vaccine Today Ahead Of Dry Run; Check Details
The applications will be reviewed by the Drugs Controller General of India for final approval after the expert panel green lights emergency use of Covid vaccines PTI Outlook Web Bureau 2021-01-01T09:25:32+05:30 Meeting On Covid-19 Vaccine Today Ahead Of Dry Run; Check Details outlookindia.com 2021-01-01T09:35:05+05:30
In a key meeting today, the applications filed for emergency use of coronavirus vaccine by the Serum Institute of India, Bharat Biotech and Pfizer will be taken up for consideration by a government-appointed panel of experts.
The meeting comes a day before the dry run for vaccination will be carried out in all states.
Coronavirus updates | January 1, 2021
Updated:
Updated:
January 01, 2021 21:49 IST
A dry run will be conducted by all the State and Union Territory governments on January 2 with the objective of preparing for the roll-out of COVID-19 vaccine across the country, the Union Health Ministry said.
Share Article
AAA
Students greets each other as schools in Kerala reopened partially after a long break, at a Girls Higher Secondary School in Thiruvananthapuram on Friday, January 1, 2021.
| Photo Credit: S. Mahinsha
A dry run will be conducted by all the State and Union Territory governments on January 2 with the objective of preparing for the roll-out of COVID-19 vaccine across the country, the Union Health Ministry said.